This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA probes kava safety amid liver injury concerns
The FDA investigates the herbal sedative kava after reports of liver toxicity in Europe and among 38 Americans under study. Canada Britain and Switzerland have acted or warned, and Germany may require prescription status. Cases include a liver transplant recipient and youths hospitalized after mixing supplements. The safety profile remains uncertain.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
FDA
Mark Blumenthal
American Botanical Council
Canada
Switzerland
Britain
Germany
National Institutes of Health
Jonathan Davidson
Duke University
South Pacific
Europe
Blumenthal